INDEX.ST

InDex Pharmaceuticals Holding AB (publ) [INDEX.ST] Stock Forecast

Buy or Sell ? Support and Resistance
What is MACD and how to read it?
How RSI can help?
RSI : 000

INDEX.ST Stock Summary

In the News

INDEX.ST Financial details

Company Rating
-
Market Cap
175.79M
Income
-92.81M
Revenue
97.51M
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
7
Optionable
No
Shortable
Yes
Earnings
22 May 2024
P/E
-3.42
Forward P/E
-
PEG
12.31
P/S
1.44
P/B
0.41
P/C
-
P/FCF
-5.57
Quick Ratio
8.49
Current Ratio
9.01
Debt / Equity
-
LT Debt / Equity
-
-
-
EPS (TTM)
-0.18
EPS next Y
-
EPS next Q
-
EPS this Y
-0%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
-16.74%
Revenue last 5Y
306.36%
Revenue Q/Q
-
EPS Q/Q
180.9%
-
-
-
-
SMA20
-
SMA50
-
SMA100
-
Inst Own
-
Inst Trans
-
ROA
-11%
ROE
-12%
ROC
-0.17%
Gross Margin
97%
Oper. Margin
-59%
Profit Margin
-43%
Payout
-
Shs Outstand
-
Shs Float
-
-
-
-
-
Target Price
-
52W Range
0.198-0.926
52W High
-
52W Low
-
RSI
-
Rel Volume
3.82
Avg Volume
2.14M
Volume
-
Perf Week
-
Perf Month
-
Perf Quarter
-
Perf Half Y
-
-
-
-
-
Beta
-0.209
-
-
Volatility
0.04%, 0.04%
Prev Close
-
Price
-
Change
-

Something similar

Top by Market Cap
FB2A.DE
BRYN.DE
ABEC.DE
M&M.NS
VTI
Same Sector
300206.SZ
LCTX
MNKD
CIPLA.NS
ATXS
Check Those
SBLK
DIM
SIFY
IBTB
1766.HK
Similar Market Cap
OTPSX
2339.HK
ROI.DE
SNFCA
GHYB

Company Profile

Healthcare Biotechnology
  • Volume Average 2.14M
  • Market Capitalization 175.79M
  • Employee 7
  • CEO Mr. Johan Gileus
  • Headquarters Solna,SE
  • IPO Date 2016-10-11
  • Website https://www.indexpharma.com

InDex Pharmaceuticals Holding AB (publ), a pharmaceutical development company, develops pharmaceutical products for patients with ulcerative colitis. The company's lead drug candidate is Cobitolimod, which is in phase III clinical development for the treatment of patients with moderate to severe ulcerative colitis. It also develops a portfolio of other DNA based immunomodulatory sequences in preclinical stage for the treatment of various immunological diseases. The company was founded in 2000 and is headquartered in Solna, Sweden.